Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P69
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 43.75% |
| Q2 2025 | 11.11% |
| Q1 2025 | -362.01% |
| Q4 2024 | 157.25% |
| Q3 2024 | 29.41% |
| Q2 2024 | 67.92% |
| Q1 2024 | -381.82% |
| Q4 2023 | -112.09% |
| Q3 2023 | 297.83% |
| Q2 2023 | 17.86% |
| Q1 2023 | 6.67% |
| Q4 2022 | -5.26% |
| Q3 2022 | -32.56% |
| Q2 2022 | -440.20% |
| Q1 2022 | 95.15% |
| Q4 2021 | -41.38% |
| Q3 2021 | 10.77% |
| Q2 2021 | -4536.86% |
| Q1 2021 | -80.47% |
| Q4 2020 | 4587.50% |
| Q3 2020 | -88.45% |
| Q2 2020 | -78.69% |
| Q1 2020 | 0.00% |
| Q3 2019 | -221.21% |
| Q2 2019 | 77.85% |
| Q1 2019 | 12.35% |
| Q4 2018 | -7.59% |
| Q3 2018 | -236.17% |
| Q2 2018 | 59.83% |
| Q1 2018 | -6.36% |
| Q4 2017 | 68.84% |
| Q3 2017 | -364.47% |
| Q2 2017 | -31.03% |
| Q1 2017 | -286.67% |
| Q4 2016 | 70.00% |
| Q3 2016 | 54.95% |
| Q2 2016 | -98.21% |
| Q1 2016 | 63.87% |
| Q4 2015 | -384.38% |
| Q3 2015 | 47.54% |